An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments become available to patients, according to physicians from two institutions involved in the effort’s initial phase. The approach will leverage electronic health records and an AI-powered platform to allow FDA scientists to track safety signals and efficacy endpoints while

Monitoring trials in real time may help shorten the time interval between trial phases.

An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments become available to patients, according to physicians from…